Drug
Cmp 001
Cmp 001: highest development phase Phase 1, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| CMP-001 NCT03084640 | Phase 1 | Malignant Melanoma |
Latest
No recent events.
Follow Cmp 001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.